|
|||||
|
|
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD |
|
| Authors: | Tetsuhiro Tanaka Masaomi Nangaku |
| Affiliation: | 1. Division of Nephrology and Endocrinology, University of Tokyo Hospital and School of Medicine, 7-3-1 Hongo, Bunkyo-ku, 113-8655 Tokyo, Japan |
| Abstract: | |
| Keywords: | chronic kidney disease (CKD) hypoxia-inducible factor (HIF) prolyl-hydroxylase domain (PHD) |
| 本文献已被 ScienceDirect 等数据库收录！ | |